| 영문 | genetic engineering | 한글 | 유전공학 |
|---|---|---|---|
| 설명 | 1. 유전자의 합성이나 변형 따위를 연구하는 학문. 응용 유전학의 한 분야로, 병의 치료나 이로운 산물의 대량 생산을 목적으로 한다. 2. 생물의 유전자를 인공적으로 가공하여 인간에게 필요한 물질을 대량으로 값싸게 얻는 기술. 1970년대에 들어서면서 경이적인 과학기술의 하나로 큰 주목을 끌고 있으며, 이 분야에는 재조합 DNA기술-세포융합기술 및 핵치환기술 등이 있다. 재조합 DNA 기술에 의하여 인공적으로 재조합유전자를 만든 최초의 보고는 1972년 잭슨 등이 하였고, 인공적 재조합유전자를 숙주세포에서 형질을 발현시키는 데 최초로 성공한 것은 1973년 F. J. 코벤 등이다. 이 재조합 DNA 기술은 세균파지, 플라스미드에 관한 연구와 DNA에 작용하는 효소들, 특히 제한효소와 DNA 연결효소에 관한 연구에 의존하였다. 유전공학의 발전은 우리 세계를 바꿀 수 있을 것으로 내다보고 있다. 암을 제압하고 노화를 방지할 수 있어 유전공학은 결국 오늘의 인간이 안고 있는 에너지-식량-의료 등의 문제를 해결해 줄 수 있는 가능성을 지닌다. 이 때문에 유전공학은 ‘제3의 산업혁명’이라고 할 수 있고, 따라서 그 개발을 위하여 온 세계의 기업들이 이의 연구개발에 착수하고 국가들도 전략기술로 다루어 집접 육성에 박차를 가하고 있다. 우리나라에서도 1982년부터 유전공학 분야를 국가가 육성해야 할 특정연구 분야로 지정하고 있다. |
||
| PE | Edinburgh Pharmacopoeia; pancreatic extract; paper electrophoresis; partial epilepsy; pelvic examina... |
|---|---|
| HCG, hCG | Human Chorionic Gonadotropin; 사람융모성성선자극호르몬 1. Placental Glycoprotein Hormone &nbs... |
| ICU | infant care unit; immunologic contact urticaria; intensive care unit; intermediate care unit |
| OILD | occupational immunologic lung disease |
| ACCE | American College of Clinical Engineering |
| biological engineering | <agriculture> A type of artificial selection, the creation of plant or animal breeds that are agriculturally or industrially useful. Compare: natural selection. (21 Mar 1998) |
|---|---|
| biomedical engineering | <orthopaedics> The use of engineering technology, instrumentation and methods to solve medical problems, such as improving our understanding of physiology and the manufacture of artificial limbs and organs. (21 Mar 1998) |
| biotechnical engineering | Civil engineering methods incorporating organic materials to produce functional structures that are also aesthetically pleasing, provide wildlife habitat, and provide sites for revegetation. (09 Oct 1997) |
| maintenance and engineering, hospital | Hospital department whose primary function is the upkeep and supervision of the buildings and grounds and the maintenance of hospital physical plant and equipment which requires engineering expertise. (12 Dec 1998) |
| genetic engineering | <molecular biology, technique> General term covering the use of various experimental techniques to produce molecules of DNA containing new genes or novel combinations of genes, usually for insertion into a host cell for cloning. (07 May 1998) |
| genetic engineering technologies | See: recombinant DNAtechnologies. (09 Oct 1997) |
| cellular engineering | <technique> The use of techniques for constructing replacement or additional or experimental parts of cells and tissues for both fundamental investigation and as prosthetic devices. Often involves the interfacing of cells and nonliving structures. (26 Mar 1998) |
| sanitary engineering | A branch of engineering concerned with the design, construction, and maintenance of environmental facilities conducive to public health, such as water supply and waste disposal. (12 Dec 1998) |
| protein engineering | Normally means the use of recombinant DNA technology to produce proteins with desired modifications in the primary sequence. See: site specific mutagenesis. (18 Nov 1997) |
| human engineering | The science of designing, building or equipping mechanical devices or artificial environments to the anthropometric, physiological, or psychological requirements of the people who will use them. (12 Dec 1998) |
| dental engineering | <dentistry> Application of engineering principles to dentistry. (05 Mar 2000) |
| engineering | Originally, the art of managing engines; in its modern and extended sense, the art and science by which the mechanical properties of matter are made useful to man in structures and machines; the occupation and work of an engineer. In a comprehensive sense, engineering includes architecture as a mechanical art, in distinction from architecture as a fine art. It was formerly divided into military engineering, which is the art of designing and constructing offensive and defensive works, and civil engineering, in a broad sense, as relating to other kinds of public works, machinery, etc. Civil engineering, in modern usage, is strictly the art of planning, laying out, and constructing fixed public works, such as railroads, highways, canals, aqueducts, water works, bridges, lighthouses, docks, embankments, breakwaters, dams, tunnels, etc. Mechanical engineering relates to machinery, such as steam engines, machine tools, mill work, etc. Mining engineering deals with the excavation and working of mines, and the extraction of metals from their ores, etc. Engineering is further divided into steam engineering, gas engineering, agricultural engineering, topographical engineering, electrical engineering, etc. Source: Websters Dictionary (01 Mar 1998) |
| adjuvants, immunologic | Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (freund's adjuvant, bcg, corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (12 Dec 1998) |
| receptors, immunologic | Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behaviour of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. (12 Dec 1998) |
| graft enhancement, immunologic | The induction of prolonged survival and growth of allografts of either tumours or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunised donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|